Muneer Abu Snineh1, Richard Camicioli2, Janis M Miyasaki3. 1. Division of Neurology, Department of Medicine, University of Alberta, Kaye Edmonton Clinic, Canada. Electronic address: abusnine@ualberta.ca. 2. Division of Neurology, Department of Medicine, University of Alberta, Kaye Edmonton Clinic, Canada. Electronic address: rcamicio@ualberta.ca. 3. Division of Neurology, Department of Medicine, University of Alberta, Kaye Edmonton Clinic, Canada. Electronic address: Miyasaki@ualberta.ca.
Abstract
INTRODUCTION: Physician Orders for Life Sustaining Therapies (POLST) or Goals of Care (GOC) are legal documents to guide intensity of interventions (ICU, resuscitation, hospitalization or comfort care) completed by healthcare professionals following counseling of patients or their designated medical decision makers. Capacity (understanding, appreciation, reasoning and expressing a choice) to consent to POLST or GOC has not been determined among Parkinson's disease (PD) patients. We sought to assess GOC PD decisional capacity for those with cognitive complaints but not dementia. METHODS: Fifty consecutive PD patients were recruited from the Movement Disorders Program. Mini Mental Status Examination (MMSE), Montreal Cognitive Assessment (MoCA) and the MacArthur Competency Assessment Test (MacCAT) for GOC were administered. RESULTS: Mean MMSE and MOCA was 27.76 and 24.5 respectively. Twenty subjects had impaired executive function. MacCAT correlated with MoCA and MMSE (p < 0.001, 0.001) but despite impaired understanding, appreciation and reasoning among some subjects, all subjects expressed a choice. CONCLUSIONS: This exploratory study demonstrates PD with cognitive concerns had a range in decisional capacity with lower MoCA and MMSE scores predicting impaired MacCAT subscores. Clinicians should be aware that cognitive complaints without dementia may impact capacity. Despite impairments in understanding, appreciation or reasoning, patients may still express a choice. Hence, a choice in this setting may not represent their true values and goals. GOC discussions require explicit determination of the domains of capacity. Discussions regarding GOC should occur early in the course of PD.
INTRODUCTION: Physician Orders for Life Sustaining Therapies (POLST) or Goals of Care (GOC) are legal documents to guide intensity of interventions (ICU, resuscitation, hospitalization or comfort care) completed by healthcare professionals following counseling of patients or their designated medical decision makers. Capacity (understanding, appreciation, reasoning and expressing a choice) to consent to POLST or GOC has not been determined among Parkinson's disease (PD) patients. We sought to assess GOC PD decisional capacity for those with cognitive complaints but not dementia. METHODS: Fifty consecutive PDpatients were recruited from the Movement Disorders Program. Mini Mental Status Examination (MMSE), Montreal Cognitive Assessment (MoCA) and the MacArthur Competency Assessment Test (MacCAT) for GOC were administered. RESULTS: Mean MMSE and MOCA was 27.76 and 24.5 respectively. Twenty subjects had impaired executive function. MacCAT correlated with MoCA and MMSE (p < 0.001, 0.001) but despite impaired understanding, appreciation and reasoning among some subjects, all subjects expressed a choice. CONCLUSIONS: This exploratory study demonstrates PD with cognitive concerns had a range in decisional capacity with lower MoCA and MMSE scores predicting impaired MacCAT subscores. Clinicians should be aware that cognitive complaints without dementia may impact capacity. Despite impairments in understanding, appreciation or reasoning, patients may still express a choice. Hence, a choice in this setting may not represent their true values and goals. GOC discussions require explicit determination of the domains of capacity. Discussions regarding GOC should occur early in the course of PD.
Keywords:
Advance care directives; Capacity to consent; Cognitive; Cognitive complaints; Executive function; Goals of Care; POLST; Parkinson's disease; Physician Orders for Life Sustaining Therapies
Authors: Hillary D Lum; Sarah R Jordan; Adreanne Brungardt; Roman Ayele; Maya Katz; Janis M Miyasaki; Anne Hall; Jacqueline Jones; Benzi Kluger Journal: Neurology Date: 2019-04-26 Impact factor: 9.910
Authors: Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven Journal: Neurooncol Pract Date: 2020-07-16
Authors: Martin Klietz; Amelie Tulke; Lars H Müschen; Lejla Paracka; Christoph Schrader; Dirk W Dressler; Florian Wegner Journal: Front Neurol Date: 2018-03-06 Impact factor: 4.003
Authors: Jennifer G Goldman; Beth A Vernaleo; Richard Camicioli; Nabila Dahodwala; Roseanne D Dobkin; Terry Ellis; James E Galvin; Connie Marras; Jerri Edwards; Julie Fields; Robyn Golden; Jason Karlawish; Bonnie Levin; Lisa Shulman; Glenn Smith; Christine Tangney; Cathi A Thomas; Alexander I Tröster; Ergun Y Uc; Noreen Coyan; Crystal Ellman; Mike Ellman; Charlie Hoffman; Susan Hoffman; Don Simmonds Journal: NPJ Parkinsons Dis Date: 2018-06-26
Authors: Herma Lennaerts-Kats; Anne Ebenau; Jenny T van der Steen; Marten Munneke; Bastiaan R Bloem; Kris C P Vissers; Marjan J Meinders; Marieke M Groot Journal: J Parkinsons Dis Date: 2022 Impact factor: 5.568
Authors: Leonard L Sokol; Michael J Young; Jack Paparian; Benzi M Kluger; Hillary D Lum; Jessica Besbris; Neha M Kramer; Anthony E Lang; Alberto J Espay; Ornella M Dubaz; Janis M Miyasaki; Daniel D Matlock; Tanya Simuni; Moran Cerf Journal: NPJ Parkinsons Dis Date: 2019-11-22